UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000008471
Receipt number R000009629
Scientific Title Post remission therapy including arsenic trioxide against acute promylocytic leukemia over 65 years old, Phase II Clinical Study (JALSG APL212G study)
Date of disclosure of the study information 2012/07/19
Last modified on 2023/01/26 15:10:55

No. Disposal Last modified on Item of update
1 Insert 2012/07/19 11:18:15
2 Update 2018/02/20 11:15:39 Email
Address
Address
TEL
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary person or sponsor
Organization
Category of Funding Organization
3 Update 2023/01/26 14:38:19 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Organization
Organization
Address
Address
Tel
Email
4 Update 2023/01/26 14:43:51 Organization
5 Update 2023/01/26 14:50:28 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2023/01/26 15:07:16 Organization
7 Update 2023/01/26 15:10:55 Organization1
Organization